Formulation and evaluation of insulin enteric microspheres for oral drug delivery

Acta Pharmaceutica Sciencia

Volumn 51, Issue 2, 2009, Pages 121-127

  Jindal, Santosh Kumar ^a   Singh, Malkeet ^b   Goswami, Manish ^a  

^a Akal College of Pharmacy and Technical Education   (India)

^b PUNJABI UNIVERSITY   (India)

Author keywords

Absorption enhancer; Enteric microspheres; Hydroxy propyl methyl cellulose acetate succinate; Insulin; Insulin oral drug delivery; Protease inhibitor

Indexed keywords

BACITRACIN; GLUCOSE; HYDROCHLORIC ACID; INSULIN; MICROSPHERE; OLEATE SODIUM; PEPSIN A; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MALE; NONHUMAN; PH MEASUREMENT; RAT; UPPER GASTROINTESTINAL TRACT;

EID: 70349690331     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bai, J.P. and Chang, L.L. (1996). Effects of enzyme inhibitors and insulin concentration on the transepithelial transport of insulin in rats. J. Pharm. Pharmacol. 48: 1078-1082.
2. Bernkop-Schnurch, A. and Thaler, S. (2000). Polycarbophil-cysteine conjugates as platforms for oral (poly)peptide delivery systems. J. Pharm. Sci. 89: 901-909. (Pubitemid 30691436)
3. Carino, G.P. and Mathowitz, E. (1999). Oral insulin delivery. Adv. Drug Del. Rev. 35: 249-257.
4. DeVries, J.H., Snoek, F.J. and Kostense, P.J. (2002). A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy I type 1 diabetes for proteins with long-standing poor glycemic control. Diabetes Care. 25: 2074-2080.
5. Donnelly, A., Kellaway, I.W., Taylor, G. and Gibson, M. (1998). Absorption enhancers as tools to determine the route of nasal absorption of peptides. J. Drug Target. 5: 121-127. (Pubitemid 28149574)
6. Herman, W.H., Ilag, L.L. and Johnson, S.L. (2005). A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 28: 1568-1573. (Pubitemid 40923066)
7. Hosny, E.A., Ghilzai, N.M.K. and Elmaza, M.M. (2006). Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate. Pharm. Acta Helvetiae. 72: 203-207.
8. Kotze, A.F., Luessen, H.L., De Boer, A.G., Verhoef, J.C. and Junginger, H.E. (1999). Chitosans for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur. J. Pharm. Sci. 7: 145-151.
9. Krauland, A.H., Guggi, D. and Bernkop-Schnurch, A. (2004). Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. J.Control. Rel. 95: 547-555. (Pubitemid 38340504)
10. Lin, S.Y., Tnan, Y.L., Lee, C.J. and Weng, C.N. (1991). Preparation of enteric coated microspheres of mycoplasma hyopneuminiae vaccine with cellulose acetate phthalate: 1. Formation condition and micromeritic properties. J. Microencapsulation. 8: 318-325.
11. Marschutz, M.K., Caliceti, P. and Bernkop-Schnurch, A. (2000). Design and in vivo evaluation of an oral delivery system for insulin. Pharm. Res. 17: 1468-1474. (Pubitemid 32217556)
12. Marschutz, M.K. and Bernkop-Schnurch, A. (2000). Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in-vitro. Biomaterials. 21: 1499-1507.
13. Martin, E., Verhoef, J.C. and Mercus, F.W. (1998) Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J. Drug Target. 6: 17-36.
14. Mathiowitz, E., Jacob, J.S., Jong, Y.S., Carino, G.P., Chickering. D.E., Chaturvedi, P., Santos, C.A., Vijayaraghavan, k., Montgomery, S., Bassett, M. and Morrell, C. (1997). Biologically erodible microspheres as potential oral drug delivery systems. Nature. 386: 410-414.
15. Modi, P., Mihic, M. and Lewin, A. (2002). The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System. Diabetes Metab. Res. Rev. 18(Suppl 1): S38-S42. (Pubitemid 34411299)
16. Morimato, K., Uehara, Y., Iwanaga, K., Kakemi, M., Ohasmi, Y., Tanaka, A. and Nakai, Y. (1998). Influence of absorption enhancer (bile salts) and the preservative (benzalkonium chloride) on mucociliary function and permeation barrier function in rabbit tracheas. Eur. J. Pharm. Sci. 6: 225-230. (Pubitemid 28473223)
17. Morishita, I., Morishita, M., Takayama, K., Machida, Y. and Nagai, T. (1993). Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. Int.J. Pharm. 91: 29-37. (Pubitemid 23121398)
18. Pickup, J., Mattock, M. and Kerry, S. (2002). Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomized control trials. B.M.J. 324: 705. (Pubitemid 34259145)
19. rd Edn.). The Folin-Lowry method of protein assay. An introduction to Practical Biochemistry. Tata McGraw-Hill Publishing Company Ltd. New Delhi, pp. 159-160.
20. Sakai, M., Imat, T., Ohtake, H. and Otagiri, M.(1998). Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J. Pharm. Pharmacol. 50: 1101-1108. (Pubitemid 28488127)
21. Schipper, N.G., Varum, K.M., Stenberg, P., Ocklind, G., Lennerlans, H. and Artusson, A.P. (1999). Chitosans as absorption enhancers of poorly absorbable drugs. 3: influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 83: 1465-1469. (Pubitemid 29325026)
22. Scott-Moncrieff, J.C., Shao, Z. and Mitra, A.K. (1994). Enhancement of intestinal absorption by bile salt-fatty acid mixed micelles in dogs. J. Pharm. Sci. 83: 1465-1469. (Pubitemid 24315285)
23. Shao, Z., Lt, Y., Chermark, T. and Mitra, A.K. (1994). Cyclodextrin as mucosal absorbance promoters of insulin: 2. Effects of β-Cyclodextrin derivatives on α-chymotrypsin degradation and enternal absorption of insulin in rats. Pharm. Res. 11: 1174-1179. (Pubitemid 24259859)
24. Shiling, R.J. and Mitra, A.K. (1991). Degradation of insulin by trysin and alpha-chymotrypsin. Pharm. Res. 8: 721-727.
25. Wu, S.J. and Robinson, J.R. (1991). Transport of human growth hormone across caco-2 cells with novel delivery agent's evidence for P-glycoprotein involvement. J. Control. Rel. 62:171-177.
26. Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M. and Muranishi, S. (1994 a). Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 1496-1500. (Pubitemid 24339662)
27. Yamamoto, A., Umemori, S. and Muranishi, S. (1994 b). Absorption enhancement of intrapulmonary administrated insulin by various absorption enhancers and protease inhibitors in rats. J.Pharm.Pharmacol. 46: 14-18. (Pubitemid 24047049)